Skip to main content
Publications
Williame C, Rosillon D, Zima J, Angelo MG, Stuurman A, Vroling H, van Staa T, Boggon R, Bunge E, Pladevall-Vila M, Baril L. Risk of autoimmune diseases (AD) after human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine immunization in women aged 9 to 25 years in the United Kingdom: an observational cohort study. Poster presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.